Nucleozin
SIGMA/N2790 - ≥98% (HPLC), powder
Synonym: Nucleozin; 1-
CAS Number: 341001-38-5
Empirical Formula (Hill Notation): C21H19ClN4O4
Molecular Weight: 426.85
MDL Number: MFCD01426660
Linear Formula: C21H19ClN4O4
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | yellow |
| form | powder |
| InChI | 1S/C21H19ClN4O4/c1-14-19( |
| InChI key | OWXBJAPOSQSWAO-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | Cc1onc(-c2ccccc2)c1C(=O)N |
| solubility | DMSO: >15 mg/mL |
| storage temp. | 2-8°C |
| Application: | Nucleozin may be used in anti-viral (anti-influenza) research to study its pharmacokinetics, metabolism, safety, efficacy and methods of delivery as an influenza A nucleoprotein (a multifunctional, RNA-binding protein necessary for virus replication) targeting drug candidate. |
| Biochem/physiol Actions: | Nucleozin targets influenza A nucleoprotein (NP), a multifunctional, RNA-binding protein necessary for virus replication. |
| Biochem/physiol Actions: | Nucleozin targets influenza A nucleoprotein (NP), a multifunctional, RNA-binding protein necessary for virus replication. Nucleozin is effective in fighting H1N1, H3N2, and H5N1 flu virus strains by inducing the formation of NP aggregates and antagonizing its nuclear accumulation, leading to cessation of viral replication. |
| Biochem/physiol Actions: | Nucleozin targets influenza A nucleoprotein, a multifunctional, RNA-binding protein necessary for virus replication. It induces the formation of nucleoptotein aggregates and inhibits its accumulation, interfering with viral replication. EC50 is in the nM range. Nucleozin is effective in H1N1, H3N2, and H5N1 flu virus strains. |
| Packaging: | 5, 25 mg in glass bottle |
| Hazard Codes | T |
| Risk Statements | 25 |
| Safety Statements | 45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

